Browsing by Author Zhou, Caicun

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2015Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsBoyer, Michael; Bennouna, Jaafar; Feng, Jifeng; Geater, Sarayut; Gorbunova, Vera; Hirsh, Vera; Hu, Cheng-Ping; Huang, Yunchao; Kato, Terufumi; Lee, Ki Hyeong; Lee, Kye Young; Lu, Shun; Massey, Dan; Mok, Tony; O'Byrne, Kenneth; Orlov, Sergey; Popat, Sanjay; Schuler, Martin; Sebastian, Martin; Sequist, Lecia; Shahidi, Mehdi; Su, Wu-Chou; Tsai, Chun-Ming; Wu, Yi-long; Yamamoto, Nobuyuki; Yang, James Chic-Hsin; Zazulina, Victoria; Zhou, Caicun; Central Clinical School: MedicineAfatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials, Lancet Oncology, vol.16, 2, 2015,pp 141-151
2017Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survivalDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Fukuoka, Masahiro; Gralla, Richard J; Inoue, Akira; Mitsudomi, Tetsuya; Mok, Tony; Nakagawa, Kazuhiko; Rosell, Rafael Costa; Thongprasert, Sumitra; Tu, Yu-Kang; Wu, Yi-long; Yang, James; Zhou, Caicun; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival, Journal of the National Cancer Institute, vol.109, 6, 2017,pp 1-13
2017Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studiesvan Zandwijk, Nico; Brustugun, O T; Buergy, D; Crino, L; Dingemans, Anne-Marie; Dusmet, Michael; Fennell, Dean; Giordano, F A; Gray, Jhanelle; Grunenwald, Dominique; Henzler, T; Huber, Rudolf Maria; Kostrzewa, M; Manegold, Christian; Meyer, M; Moniuszko, Marcin; Mornex, Francoise; Papotti, M; Perol, Maurice; Pilz, Lothar; Rathmann, N; Roessner, Eric Dominic; Schabel, Christoph; Senan, Suresh; Syrigos, K; van Meerbeeck, Jan; Vliegenthart, R; Voigt, Weiland; Zhou, Caicun; Concord Clinical School: MedicineManagement of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies, Journal of Thoracic Oncology, vol.12, 12, 2017,pp 1755-1765
2010Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyPavlakis, Nick; Crino, Lucio; Dansin, Eric; Garrido, Pilar; Griesinger, Frank; Laskin, Janessa; Stroiakovski, Daniel; Thatcher, N; Tsai, Chun-Ming; Wu, Yi-long; Zhou, Caicun; Northern Clinical School: MedicineSafety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study, Lancet Oncology, vol.11, 8,pp 733-740